Financial Data and Key Metrics Changes - Tilray achieved record annual revenue of $821 million, a 4% increase year over year on a constant currency basis, and $834 million, a 6% increase year over year [7][34] - The company reported a gross profit of $241 million, an 8% increase year over year, and the highest gross margin at 29%, up from 28% in the prior year [8][40] - A net loss for fiscal year 2025 increased to $2.2 billion, or $2.46 per share, compared to a loss of approximately $220 million in the prior year [41][50] Business Line Data and Key Metrics Changes - International cannabis revenue reached $22.4 million in Q4, up 71% year over year, with a full year growth of approximately 20% [7][14] - The beverage segment reported net revenue of $65.6 million in Q4, a 19% year-over-year increase, although impacted by SKU rationalization initiatives [24][38] - Wellness revenue grew by 9% to over $60 million, driven by the expansion of the Manitoba Harvest brand and new product innovations [29][30] Market Data and Key Metrics Changes - In Canada, Tilray maintained a 9.3% market share in the adult recreational segment, with a total cannabis revenue of $186 million for the fiscal year [18][12] - The international cannabis business showed significant growth, particularly in Germany, where revenue grew by 134% year over year in Q4 [15][12] - The U.S. beverage division generated approximately $240 million in sales, with a focus on expanding market share in the non-alcoholic beverage sector [13][28] Company Strategy and Development Direction - The company is focused on solidifying its global leadership in cannabis and expanding its beverage and wellness business through innovation and strategic acquisitions [6][12] - Tilray aims to strengthen its balance sheet through strategic debt restructuring and has reduced its net debt to EBITDA ratio to 0.3 times from 1.7 last year [9][41] - The company is optimistic about future growth opportunities in international markets, particularly in Europe and emerging markets [17][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term strategy despite recent non-cash impairment charges, emphasizing the intrinsic value of tangible assets and brand equity [11][43] - The Canadian cannabis market is stabilizing, with expectations of regulatory reforms that could enhance market conditions [17][65] - Management anticipates continued growth in international cannabis markets, particularly in Germany, Poland, and the UK, with significant plans for expansion [70][72] Other Important Information - The company implemented strategic initiatives that impacted revenue by approximately $35 million due to decisions aimed at enhancing margins and profitability [7][35] - The beverage business faced challenges due to softer consumer demand and unexpected distribution headwinds, but corrective actions are being taken to improve performance [24][26] - Tilray's wellness segment is expected to expand further in fiscal year 2026, focusing on better-for-you functional foods and beverages [31][30] Q&A Session Summary Question: What is the current status of importing rights and delays? - Management indicated that legal issues in Portugal are being resolved, and they expect to start shipping products soon, with an estimated $8 million in sales impacted by trapped shipments [60][61] Question: Can you elaborate on the Canadian market's equilibrium and price pressures? - Management noted that the Canadian market is stabilizing with more retail stores opening, leading to increased consumer preference for legal cannabis over illicit products, and potential regulatory changes could further enhance market conditions [63][65] Question: How should growth in international markets be viewed for next year? - Management expressed optimism about international growth, particularly in Germany and other European markets, with significant plans for expansion and a focus on medical cannabis [70][72]

Core Insights - Tilray Brands, Inc. reported a fiscal year net revenue of $821 million, with a constant currency revenue of $834 million, impacted by strategic decisions that affected revenue by $35 million [1][12] - The company achieved its second-highest consolidated adjusted EBITDA in history during Q4 [1] - International cannabis revenue surged by 71% in Q4 and 19% for the fiscal year, with Canadian cannabis maintaining the top revenue position [1][4] - Tilray Beverages and Tilray Wellness experienced revenue growth of 19% and 9%, respectively, for the fiscal year [1][11] Financial Performance - Fiscal year 2025 net revenue increased by 4% to $821.3 million compared to $788.9 million in the prior fiscal year [13] - Gross profit for the fiscal year rose by 8% to $240.6 million, with a gross margin of 29% [13] - Cannabis net revenue for fiscal 2025 was $249 million, down from $272.8 million in the previous year, primarily due to strategic margin preservation efforts [13][11] - Adjusted EBITDA for fiscal 2025 was $55 million, compared to $60.5 million in the prior fiscal year [13] Strategic Initiatives - The company is focusing on international growth, with a 19% increase in international cannabis revenue and a 112% growth in European cannabis revenue when excluding Australia [4][5] - Tilray has made strategic acquisitions in the beverage sector, acquiring four craft brands from Molson Coors to enhance its market presence [6] - The introduction of hemp-derived Delta-9 THC drinks in the U.S. is part of Tilray's strategy to innovate at the intersection of cannabis, beverages, and wellness [7] Balance Sheet and Liquidity - Tilray reported a strong balance sheet with $256 million in cash and marketable securities, and total debt repayments of approximately $100 million to date [2][8] - The net debt to trailing twelve months adjusted EBITDA ratio stands at 0.3x, indicating strong financial health [8] Future Outlook - For fiscal year 2026, the company expects adjusted EBITDA to be between $62 million and $72 million, representing growth of 13% to 31% compared to fiscal year 2025 [12][11] - The company anticipates significant growth opportunities in cannabis, beverage, and wellness sectors, particularly in Europe and emerging markets [3][4]

Industry Trend - AI is poised to democratize access to personalized wellness services, making them available to a broader population at a significantly lower cost [1] - AI and AI-powered products are expected to substantially reduce the cost of wellness-related offerings, particularly those delivered digitally [2] Wellness Service - Currently, luxury wellness includes services like wellness coaches and personal trainers, which are expensive and accessible only to a small fraction of the population [1]

Market Overview & Growth - The global wellness wearables market is on the rise, with IDC expecting revenues to grow from $63 billion in the past year to nearly $78 billion by 2029 [4][5] - WOOP experienced 70% year-over-year growth in the last 12 months, driven by its expansion from a primarily US business to a global presence in 50 markets [24][25] Competitive Landscape & Differentiation - The wellness wearables arena is crowded, attracting billions in investment and spawning new startups regularly [9] - Khosla Ventures seeks unique, protectable technology with IP that offers unique benefits in the competitive wearables landscape [12] - WOOP differentiates itself through technology, using sophisticated biometric monitoring and data collection for more actionable health insights, focusing on accuracy and specific health outcomes rather than being a general smartwatch [15][16][17] Technology & Innovation - Wearable technology is evolving from providing insights to offering therapeutic interventions [18][19][33] - AI is being used to improve algorithms for sensing in wearables, leading to better performance and accuracy [30] - Flow Neuroscience uses gentle electric stimulation to treat mild to moderate depression, with clinical trials showing about 16% improvement in remission in depressive symptoms compared to 20% in placebo [21][22] Company Specifics (WOOP) - WOOP was valued at $3.6 billion as of its last funding round in 2021 [6] - WOOP's latest models, WOOP 5.0 and WOOP emoji, feature a 14-day battery life and more accurate sensing, with medical clearances for EKG monitoring, AFib detection, and blood pressure insights [17] Future Trends & Potential - Wearables have the potential to replace or reduce the frequency of visits to the doctor's office [34] - Wearable technologies, along with other monitoring devices, may eventually be the answer to capturing and correcting diseases early on [32]

Core Insights - Limitless X Holdings, Inc. has secured a $250,000 bridge financing facility through a related-party transaction with its Chairman and CEO, Jas Mathur, indicating strong insider confidence in the company's long-term vision and strategic roadmap [1][2][3] Financing Details - The financing is structured as a 12-month promissory note with a compelling yield, reflecting strong insider support and confidence in the company's long-term strategy [2] - EM1 Capital LLC received an equity incentive package, including restricted equity and performance-aligned warrants, designed to reward long-term belief in the company's vision [2] Leadership Confidence - The internal capital commitment by the founder and largest shareholder sends a clear message of leadership confidence to the market [3] - Jas Mathur emphasized that this investment is a belief in the team and the mission, positioning the company to be a market leader in transformational wellness [4] Capital Allocation - The capital will be allocated toward core operations, regulatory compliance, corporate initiatives, and the initial rollout of offline sales channels [4] - It will also support the early-phase development of HealthMD.com, a subsidiary aimed at enhancing the company's long-term wellness strategy [4] Market Positioning - The global wellness market exceeds $5 trillion, with increasing demand for hyper-personalized health solutions, positioning Limitless X at the intersection of technology, diagnostics, and lifestyle optimization [5] - Direct funding from Mr. Mathur aligns executive leadership with shareholders, signaling conviction amid the company's expansion [5] Company Overview - Limitless X Holdings, Inc. is building a value-driven ecosystem focused on health, wellness, entertainment, community building, and brand development [6] - The company specializes in Direct-to-Consumer eCommerce, offering innovative products and services to empower individuals [6] Expansion Plans - The company is expanding into the Film and Television sector, developing content aligned with its core philosophy [7] - Plans to enter the Real Estate sector through High-Performance Healthy Living, creating wellness-focused residential communities [7] Global Strategy - Limitless X aims to grow its global distribution footprint and international presence, bringing wellness-focused products to consumers worldwide [8] - The company leverages advanced digital marketing strategies and strategic partnerships to drive long-term shareholder growth and community impact [8]

Core Viewpoint - Tilray Brands, Inc. is set to release its financial results for the fourth quarter and full fiscal year ended May 31, 2025, on July 28, 2025, after market close [1] Group 1: Financial Results Announcement - The financial results will be announced after market close on July 28, 2025 [1] - A live conference call and audio webcast will be held to discuss these results at 4:30 PM Eastern Time on the same day [2] Group 2: Company Overview - Tilray is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America [3] - The company focuses on the cannabis, beverage, wellness, and entertainment industries, aiming to elevate lives through moments of connection [3] - Tilray supports over 40 brands in over 20 countries, offering comprehensive cannabis products, hemp-based foods, and craft beverages [3]

Core Insights - Hims & Hers Health, Inc. (HIMS) is transforming health and wellness through a consumer-first digital platform, providing treatment for chronic and sensitive conditions, and has conducted over 30 million telehealth consultations in the U.S. and U.K. [1][7] Company Overview - HIMS offers accessible care for mental health, dermatology, sexual wellness, and weight management via its mobile app [7] - The company is expanding its services to include lab testing, compounded medications, and personalized digital wellness solutions [7] Industry Trends - According to McKinsey's 2025 Future of Wellness Trends survey, wellness is increasingly important to consumers, especially Gen Z and millennials, leading to a demand for accessible, science-backed, and personalized solutions [3] - Hims & Hers is well-positioned in the evolving wellness industry with a scalable, tech-enabled model that emphasizes individualized care and proactive health management [3] Competitive Landscape - LifeMD, Inc. (LFMD) focuses on direct-to-patient telehealth services for lifestyle and chronic health conditions, expanding its offerings in accessible digital healthcare [4] - Medifast, Inc. (MED) emphasizes lifestyle-based weight management through its OPTAVIA program, supporting over 25,000 active coaches and impacting over 3 million lives [5] Financial Performance - HIMS shares have increased by 90.6% year-to-date, significantly outperforming the industry growth of 9.9% [6] - The Zacks Consensus Estimate predicts a 174.1% increase in HIMS' earnings per share from 2024 to 2025 [8] Valuation Metrics - HIMS has a forward 12-month price-to-sales (P/S) ratio of 4.1X, which is lower than the industry average of 5.8X but higher than its three-year median of 2.3X [10]

Core Viewpoint - Tilray Brands, Inc. announced the approval of a reverse stock split at a ratio of 1-to-10 to 1-to-20, but has paused its implementation to evaluate timing and stock price [1][2]. Financial Structure - In the fiscal quarter ended February 28, 2025, Tilray reduced its total debt by approximately $76 million, resulting in a net debt to trailing twelve-months Adjusted EBITDA of less than 1.0x [3]. - As of the last fiscal quarter, Tilray's cash and marketable securities balance was approximately $250 million, providing financial strength and flexibility for strategic opportunities and acquisitions [3]. Strategic Objectives of Reverse Stock Split - The reverse stock split aims to ensure compliance with Nasdaq listing requirements, align the number of shares with similar companies, attract institutional shareholders, and potentially save up to $1 million annually in costs associated with stockholder meetings [7].

Group 1 - Tilray Brands, Inc. will participate in the TD Cowen 9th Annual Future of the Consumer Conference on June 3, 2025, in New York, with a fireside chat scheduled for 11:00 a.m. ET [1] - The company is recognized as a global leader in the lifestyle and consumer packaged goods sector, focusing on cannabis, beverage, wellness, and entertainment industries [3] - Tilray operates in multiple regions including Canada, the United States, Europe, Australia, and Latin America, supporting over 40 brands in more than 20 countries [3]

TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, is excited to announce that its wholly-owned subsidiary, High Park Holdings Ltd., is launching XMG Atomic Sours, a new line of cannabis beverages and gummies that redefine the sour experience. XMG Atomic Sours includes two cannabis-infused drinks, Cherry Blasted Lime and Foggy Peaches, and two cannabis- ...